Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections.
We evaluated costs and outcomes of patients with S. aureus bacteremia and orthopedic device infections (ODI). Patients with ODI had higher relapse of S. aureus infection, compared to bacteremic patients without ODI. Costs and outcomes were similar among ODI patients undergoing device removal and those treated with debridement and retention.
Lalani
Tahaniyat
T
Duke Clinical Research Institute, 2400 Pratt Street, Cube 7545, Durham, NC 27710, USA. lalan002@mc.duke.edu
Chu
Vivian H
VH
Grussemeyer
Chelsea A
CA
Reed
Shelby D
SD
Bolognesi
Michael P
MP
Friedman
Joelle Y
JY
Griffiths
Robert I
RI
Crosslin
David R
DR
Kanafani
Zeina A
ZA
Kaye
Keith S
KS
Ralph Corey
G
G
Fowler
Vance G
VG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000191:economics / Q000382:microbiology*; D001858:Bone Nails / Q000009:adverse effects; D001860:Bone Plates / Q000009:adverse effects; D016267:External Fixators / Q000009:adverse effects; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000150:complications* / Q000191:economics*; D013203:Staphylococcal Infections / Q000150:complications* / Q000191:economics*; D013211:Staphylococcus aureus; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents